Table 2.
Inclusion criteria | Exclusion criteria |
1. Enrolled in the screening intervention | 1. History of serious liver or kidney disease. |
2. Not eligible for any other rifamycin-based treatment | 2. Known pregnancy (SDR can be given after delivery). |
3. Aged ≥2 years | 3. Known allergy or severe adverse effects experienced with rifampicin use. |
4. Informed consent. For children (<18 years) consent will be obtained from the parent or guardian, and children (≥10 years) will also provide assent. | 4. Refuses participation. |
Inclusion criteria are shown for single dose rifampicin. Other treatment regimens are determined by indications and contraindications relevant to those regimens.
SDR, single-dose rifampicin.